Background illustration for clinical trials search

Paid Clinical Trials Birmingham

Discover 889 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Homewood AL, Atlanta GA, Canton OH, Detroit MI,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase2, Recruiting

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

for
Non-small Cell Lung Cancer
Location: Birmingham AL, Roanoke VA, Lafayette IN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07190248

Phase3, Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

for
Early Breast Cancer
Location: Birmingham AL, Nashville TN, Jackson MS, Greenville SC,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05827081

Phase3, Recruiting

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

for
Non-small Cell Lung Cancer
Location: Birmingham AL, Nashville TN, Knoxville TN,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712316

Phase2, Phase3, Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Birmingham AL, Nashville TN, Carbondale IL, O'Fallon IL,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT07211178

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

for
APOL1-Mediated Kidney Disease
Location: Irondale AL, Birmingham AL, Alabaster AL, Tupelo MS,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 65

Code: NCT06824987

Phase2, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Birmingham AL, Atlanta GA, Nashville TN, Augusta GA,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting

Study of Olverembatinib (HQP1351) in Patients With CML-CP

for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Birmingham AL, Newnan GA, Chattanooga TN, Nashville TN,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06423911

Phase3, Recruiting

Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test

for
COVID-19, COVID
Location: Birmingham AL, Madison AL, Baton Rouge LA
Sponsor: Aptitude Medical Systems

Sex: All

Age: 2+

Code: NCT06744660

Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Birmingham AL, Nashville TN, Baton Rouge LA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06129864

Phase3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Birmingham AL, Atlanta GA, Nashville TN, Charlotte NC,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase1, Phase2, Recruiting

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

for
Obesity, Overweight, Chronic Weight Management,
Location: Birmingham AL, Woodstock GA, Atlanta GA,
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07654374

Phase3, Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Birmingham AL, Germantown TN, Louisville KY,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase3, Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Birmingham AL, Nashville TN, Decatur IL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

for
Lichen Planopilaris
Location: Birmingham AL, Murfreesboro TN, Smyrna TN,
Sponsor: Priovant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07532603

Phase2, Phase3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Birmingham AL, Vestavia Hills AL, Athens AL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Birmingham AL, Chattanooga TN, Franklin TN,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT07082738

Phase2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Birmingham AL, Huntsville AL, Tupelo MS, Atlanta GA,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

for
Hyperkalaemia
Location: Birmingham AL, Columbia SC, Cincinnati OH, Baltimore MD,
Sponsor: AstraZeneca

Sex: All

Age: 0 - 18

Code: NCT03813407

Phase3, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for
Heart Failure
Location: Birmingham AL, Vestavia Hills AL, Centreville AL,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase3, Recruiting